Your shopping cart is currently empty

PI3KC2γ-IN-1 (Compound 23) is an orally active and selective inhibitor of PI3KC2γ with an IC50 of 4 nM. It downregulates the Akt2-glycogen synthase (GS) signaling pathway, ultimately inhibiting the conversion of glucose to glycogen and reducing excessive glycogen accumulation in the liver. PI3KC2γ-IN-1 significantly inhibits insulin-induced accumulation of PI(3,4)P2 in primary hepatocytes and HepG2 liver cancer cells. It is useful for researching glycogen storage diseases (GSDs).
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PI3KC2γ-IN-1 (Compound 23) is an orally active and selective inhibitor of PI3KC2γ with an IC50 of 4 nM. It downregulates the Akt2-glycogen synthase (GS) signaling pathway, ultimately inhibiting the conversion of glucose to glycogen and reducing excessive glycogen accumulation in the liver. PI3KC2γ-IN-1 significantly inhibits insulin-induced accumulation of PI(3,4)P2 in primary hepatocytes and HepG2 liver cancer cells. It is useful for researching glycogen storage diseases (GSDs). |
| Targets&IC50 | PI3KC2γ:4 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.